0.99
10.81%
-0.12
Anebulo Pharmaceuticals Inc (ANEB) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
39.71%
1.6643
|
2.7605 | 2.5437 | 2.4944 | 2.864 |
Operating Income/Loss |
39.71%
-1.6643
|
-2.7605 | -2.5437 | -2.4944 | -2.864 |
Nonoperating Income/Loss |
75.15%
0.0107
|
0.0431 | 0.0629 | - | - |
Income/Loss From Continuing Operations Before Tax |
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
Income/Loss From Continuing Operations After Tax |
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
Net Income/Loss
|
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.56%
25.93
|
25.79 | 25.63 | 0.1856 | 25.63 |
Diluted Average Shares |
0.56%
25.93
|
25.79 | 25.63 | - | - |
Basic Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | 0.84 | -0.11 |
Diluted Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):